IL-2K35C-moFA, a Long-Acting Engineered Cytokine with Decreased Interleukin 2 Receptor α Binding, Improved the Cellular Selectivity Profile and Antitumor Efficacy in a Mouse Tumor Model.

Autor: Wang, Xiaoze1,2 (AUTHOR), Chen, Gang3 (AUTHOR), Nie, Lei2 (AUTHOR), Wu, Zhenhua2 (AUTHOR), Wang, Xinzeng2 (AUTHOR), Pan, Chenxiao2 (AUTHOR), Chen, Xuchen2 (AUTHOR), Zhao, Xiaobei3 (AUTHOR), Zhu, Jie3 (AUTHOR), He, Qiaojun1 (AUTHOR), Wang, Haibin2 (AUTHOR) haibin.wang@bioraypharm.com
Zdroj: Cancers. Oct2022, Vol. 14 Issue 19, p4742. 13p.
Databáze: Academic Search Ultimate